The DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index.
Tyrosine hydroxylase phosphorylation: regulation and consequences
Open accessAbstract
The rate‐limiting enzyme in catecholamine synthesis is tyrosine hydroxylase. It is phosphorylated at serine (Ser) residues Ser8, Ser19, Ser31 and Ser40 in vitro, in situ and in vivo. A range of protein kinases and protein phosphatases are able to phosphorylate or dephosphorylate these sites in vitro. Some of these enzymes are able to regulate tyrosine hydroxylase phosphorylation in situ and in vivo but the identity of the kinases and phosphatases is incomplete, especially for physiologically relevant stimuli. The stoichiometry of tyrosine hydroxylase phosphorylation in situ and in vivo is low. The phosphorylation of tyrosine hydroxylase at Ser40 increases the enzyme's activity in vitro, in situ and in vivo. Phosphorylation at Ser31 also increases the activity but to a much lesser extent than for Ser40 phosphorylation. The phosphorylation of tyrosine hydroxylase at Ser19 or Ser8 has no direct effect on tyrosine hydroxylase activity. Hierarchical phosphorylation of tyrosine hydroxylase occurs both in vitro and in situ, whereby the phosphorylation at Ser19 increases the rate of Ser40 phosphorylation leading to an increase in enzyme activity. Hierarchical phosphorylation depends on the state of the substrate providing a novel form of control of tyrosine hydroxylase activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-Synuclein activates stress-related protein kinases to potentiate TH phosphorylation at serine 40, suggesting the possible mechanism of pSer40-TH elevation by α-synuclein aggregation [52,124,125].”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Intricate Regulation of Tyrosine Hydroxylase Activity and Gene Expression
Kumer, S. C., & Vrana, K. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020443.x · Cited by 680
Complete coding sequence of rat tyrosine hydroxylase mRNA.
Grima, B., Lamouroux, A., Blanot, F., Biguet, N. F., & Mallet, J. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.617 · Cited by 534
Tetrahydropterin-Dependent Amino Acid Hydroxylases
Fitzpatrick, P. F. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.355 · Cited by 514
Sumi, M., Kiuchi, K., Ishikawa, T., Ishii, A., Hagiwara, M., Nagatsu, T., & Hidaka, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)92031-e · Cited by 511
Udenfriend, S. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07173-x · Cited by 503
Zigmond, R. E., Schwarzschild, M. A., & Rittenhouse, A. R. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.002215 · Cited by 495
Grima, B., Lamouroux, A., Boni, C., Julien, J., Javoy-Agid, F., & Mallet, J. J. (1987) · Nature · doi:10.1038/326707a0 · Cited by 351
Pterin-Dependent Amino Acid Hydroxylases
Kappock, T. J., & Caradonna, J. P. (1996) · Chemical Reviews · doi:10.1021/cr9402034 · Cited by 331
JOH, T. H., Park, D. H., & Reis, D. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4744 · Cited by 284
Research works printed but not linked: 4
- 10.1042/bj3510095 · DOI
- Haycock J. W., 1993, Phosphorylation of tyrosine hydroxylase isoforms in human neuroblastoma cells, Mol. Biol. Cell, 41, 406a
- Waymire J., 1993, Multiple site phosphorylation and activation of tyrosine hydroxylase, Adv. Prot. Phosphatases, 7, 495
- Yamauchi T., 1980, Involvement of calmodulin in the Ca2+‐dependent activation of rat brainstem tyrosine 3‐monooxygenase, Biochem. Int., 1, 98
Cited by
Sorted by citations
Items 201–300 of 456
Holahan, M. R., Madularu, D., McConnell, E. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022239 · Cited by 22
“The synthesis and secretion of dopamine is critically dependent on TH activation through phosphorylation taking place at serine residues (Ser) 8, 19, 31 and 40 [36].”
BackgroundLiu, B., & Arbogast, L. A. (2007) · Endocrinology · doi:10.1210/en.2007-1345 · Cited by 22
Kleppe, R., Rosati, S., Jorge‐Finnigan, A., Alvira, S., Ghorbani, S., Haavik, J., Valpuesta, J., Heck, A. J. R., & Martı́nez, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035709 · Cited by 22
“An optimal complex formation for the activation of TH would not inhibit Ser40 phosphorylation, which is the site that gives the strongest activation of the enzyme (5, 14).”
Aquino-Miranda, G., Escamilla‐Sánchez, J., González-Pantoja, R., Bueno-Nava, A., & Arias‐Montaño, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.006 · Cited by 22
“, 2000), but this phosphatase appears inactive at TH Serine40 (Dunkley et al., 2004).”
BackgroundInfluentialHamid, T., Xu, Y., Ismahil, M. A., Li, Q., Jones, S. P., Bhatnagar, A., Bolli, R., & Prabhu, S. D. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00904.2015 · Cited by 22
“6A, mRNA expression of tyrosine hydroxylase (TH), which catalyzes the rate-limiting step of catecholamine biosynthesis in adrenergic neurons (11), increased in all three CSC groups (and significantly so in”
BackgroundKidney dopamine D 1 -like receptors and angiotensin 1–7 interaction inhibits renal Na + transporters
Banday, A. A., Díaz, A. D., & Lokhandwala, M. F. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00135.2019 · Cited by 22
Franco, J. L., Posser, T., Gordon, S. L., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp245 · Cited by 21
“2) is the first and rate-limiting step in the synthesis of the catecholamines dopamine (DA), noradrenaline, and adrenaline (Dunkley et al., 2004).”
Self-citationRedox Sensitivity of Tyrosine Hydroxylase Activity and Expression in Dopaminergic Dysfunction
Giovanni, G. D., Pessia, M., & Maio, R. D. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792938 · Cited by 21
“Phosphorylation of Ser residues on TH can differently affect not only the activity but also enzyme stability or its degradation [37].”
Shin, S. S., Bray, E. R., & Dixon, C. E. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.1966 · Cited by 23
“Increased pser19TH induces conformational change of TH, allowing phosphorylation at serine 40 (pser40TH) at an increased rate (Dunkley et al., 2004).”
BackgroundInfluentialStayte, S., Rentsch, P., Tröscher, A. R., Maximilian, B., Li, K. M., & Vissel, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0167211 · Cited by 21
Bairam, A., Joseph, V., Lajeunesse, Y., & Kinkead, R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.030 · Cited by 24
“(Kumer and Vrana, 1996; Dunkley et al., 2004).”
Calvo, A. C., Pey, A. L., Miranda‐Vizuete, A., et al. (2010) · Biochemical Journal · doi:10.1042/bj20101561 · Cited by 21
Skelding, K. A., Suzuki, T., Gordon, S. L., Xue, J., Verrills, N. M., Dickson, P. W., & Rostas, J. A. P. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.011 · Cited by 21
Self-citationBaumann, A., Jorge-Finnigan, A., Jung-KC, K., Sauter, A., Horvath, I., Morozova-Roche, L. A., & Martinez, A. (2016) · Scientific Reports · doi:10.1038/srep39488 · Cited by 20
Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20
“It is reported that Ser40 phosphorylation of TH enhances in vitro, in situ, and in vivo enzyme activity [53].”
BackgroundMyeloid adrenergic signaling via CaMKII forms a feedforward loop of catecholamine biosynthesis
Luo, Y., Liu, B., Yang, X., Ma, X., Zhang, X., Евгеньевич, Б. Д., Yang, X. O., Huang, W., & Liu, M. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx046 · Cited by 20
García-Carmona, J. A., Georgiou, P., Zanos, P., Bailey, A., & Laorden, M. L. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1470-z · Cited by 20
Lamanna, J., Isotti, F., Ferro, M., Racchetti, G., Anchora, L., Rucco, D., & Malgaroli, A. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24732 · Cited by 20
4 Aromatic Amino Acids in the Brain
Cansev, M., & Wurtman, R. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-30373-4_4 · Cited by 22
“Phosphorylation at the Ser19 position sensitizes the TH to the subsequent phosphorylation of its Ser40 moiety, which increases the enzyme’s net activity, both in vitro and in vivo (Dunkley et al., 2004).”
Selective catecholamine detection in living cells by a copper-mediated oxidative bond cleavage
Tong, K. Y., Zhao, J., Tse, C., Wan, P., Rong, J., & Au‐Yeung, H. Y. (2019) · Chemical Science · doi:10.1039/c9sc03338f · Cited by 20
Wang, Y., Sung, C. C., & Chung, K. K. K. (2017) · Scientific Reports · doi:10.1038/srep44154 · Cited by 20
“Studies have found that TH’s enzymatic activity can be regulated by phosphorylation of the N-terminal regulatory domain of TH 2,8 .”
Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
Kawahata, K., & Fukunaga, K. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.12.003 · Cited by 20
Liu, Y., Wang, Y., Zhang, X., Jiao, Y., Duan, L., Dai, L., & Yan, H. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116190 · Cited by 21
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
Valsecchi, V., Errico, F., Bassareo, V., Marino, C., Nuzzo, T., Brancaccio, P., Laudati, G., Casamassa, A., Grimaldi, M., D’Amico, A., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05543-1 · Cited by 22
“We found that SMN de fi ciency in the late-symptomatic SMN Δ 7 mouse brain triggers increased DA levels and TH phosphorylation at Ser40 residue, likely enhancing its enzymatic activity 75 .”
The Sustained Phase of Tyrosine Hydroxylase Activation In vivo
Ong, L. K., Sominsky, L., Dickson, P. W., Hodgson, D. M., & Dunkley, P. R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0812-3 · Cited by 19
“catecholamine binding, and increases TH activity both in vitro and in vivo [24, 32, 33].”
BackgroundSelf-citationKim, S. S., Moon, K. R., & Choi, H. J. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0518-0 · Cited by 19
“Alpha-SYN attenuates forskolin-induced TH upregulation, but not TH phosphorylation TH expression and its phosphorylation are tightly controlled in response to various stimuli (Kumer and Vrana, 1996; Dunkley et al., 2004), and cAMP/PKA/ CRE-related signaling is known to play a crucial role in both short-term (phosphory…”
BackgroundInfluentialStriatal Dopamine Homeostasis is Altered in Mice Following Roux-en-Y Gastric Bypass Surgery
Reddy, I. A., Wasserman, D. H., Ayala, J. E., Hasty, A. H., Abumrad, N. N., & Galli, A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500137d · Cited by 19
Wallace, L. J. (2007) · Synapse · doi:10.1002/syn.20408 · Cited by 19
“thought to lead to phosphorylation of Ser40 on the TH protein, which decreases activity of the enzyme (Dunkley et al., 2004; Lindgren et al., 2001, 2003).”
BackgroundInfluentialKawahata, K., & Fukunaga, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317037 · Cited by 17
“…of TH is facilitated mainly by the cAMP-dependent protein kinase (PKA), Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), and also stress-responsive enzymes, including mitogen-activated protein kinase activated protein kinase (MAPKAPK) and mitogen-and stress-activated kinase 1 (MSK1) [87,88].”
BackgroundBoosting serotonin in the brain: is it time to revamp the treatment of depression?
Torrente, M. P., Gelenberg, A. J., & Vrana, K. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111430744 · Cited by 19
“Such hierarchical phosphorylation has been shown to occur for TH both in vitro and in situ: phosphorylation of TH at Ser19 increases the rate of Ser40 phosphorylation leading to an increase in the enzyme’s activity (Dunkley et al., 2004).”
Ghorbani, S., Szigetvari, P. D., Haavik, J., & Kleppe, R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14872 · Cited by 18
Endogenous Dopamine Is Involved in the Herbicide Paraquat-Induced Dopaminergic Cell Death
Izumi, Y., Ezumi, M., Takada‐Takatori, Y., Akaike, A., & Kume, T. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu054 · Cited by 18
Liu, B., & Arbogast, L. A. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0335 · Cited by 18
Navarro‐Zaragoza, J., Laorden, M. L., & Milanés, M. V. (2015) · Addiction Biology · doi:10.1111/adb.12328 · Cited by 18
“…of TH at Ser 31, it is important to highlight that short-term regulation of catecholamine biosynthesis occurs through phosphorylation of TH and as explained previously, that phosphorylation of TH could be at Serine 31 and/or Serine 40 (Haycock 1993; Kumer & Vrana 1996; Dunkley et al. 2004).”
BackgroundInfluentialSenthilkumaran, M., Johnson, M., & Bobrovskaya, L. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1875-3 · Cited by 19
“We have previously found that the glucoprivic agent 2-deoxyglucose (2DG), increases Ser31 and Ser40 TH phosphorylation in the adrenal gland of rats within 60 min stimulation, in parallel with increased plasma adrenaline levels, suggesting that TH may be activated to replenish the catecholamines released in response to…”
BackgroundInfluentialSelf-citationHe, D., & Dorit Ron, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706216200 · Cited by 17
Chertkow, Y., Weinreb, O., Youdim, M. B. H., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0753-1 · Cited by 17
Nedoboy, P. E., Mohammed, S., Kapoor, K., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.012 · Cited by 17
Intracellular Stability of Tyrosine Hydroxylase
Nakashima, A., Kaneko, Y. S., Kodani, Y., Mori, K., Nagasaki, H., Nagatsu, T., & Ota, A. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00001-4 · Cited by 17
Kunzler, A., Ribeiro, C. T., Gasparotto, J., Petiz, L. L., da Rosa, H. T., da Silva, J. D., Bortolin, R. C., de Souza, P. O., Barreto, F., Espitia-Pérez, P., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.002 · Cited by 20
“Dopamine production can be upregulated by the modulation of TH activity in the remaining cells, a common response to dopaminergic neurodegeneration in order to compensate for dopaminergic loss (Dunkley et al., 2004).”
Wasinski, F., Chaves, F. M., Pedroso, J. A. B., Mansano, N. D. S., Camporez, J. P., Gusmão, D. O., List, E. O., Kopchick, J. J., Frazão, R., Szawka, R. E., et al. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12957 · Cited by 17
A Zebrafish Model of Neurotoxicity by Binge-Like Methamphetamine Exposure
Bedrossiantz, J., Bellot, M., Domínguez-García, P., Faria, M., Prats, E., Gómez‐Canela, C., López‐Arnau, R., Escubedo, E., & Raldúa, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770319 · Cited by 16
“Treatment with high doses of METH induces a significant increase in PKCδ expression in the striatum, an effect resulting in a significant inhibition of TH activity by phosphorylation at Ser40 (Dunkley et al., 2004).”
BackgroundJensik, P. J., & Arbogast, L. A. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02197.x · Cited by 16
Ong, L. K., Bobrovskaya, L., Walker, F. R., Day, T. A., Dickson, P. W., & Dunkley, P. R. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0255-7 · Cited by 16
“Ser40, Ser31 and Ser19 have all been found to be phosphorylated in vivo in the brain under resting conditions [11] and in response to a range of drugs [9, 12].”
BackgroundInfluentialSelf-citationBrodnik, Z. D., Double, M., España, R. A., & Jaskiw, G. E. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.030 · Cited by 16
“Cytosolic DA competes with reduced tetrahydrobiopterin for binding of Fe+2, and in addition forms a nearly irreversible, inactive TH-DA-Fe+3 complex (Dunkley et al., 2004;Kumer and Vrana, 1996).”
BackgroundZhang, X., Mantas, I., Alvarsson, A., Yoshitake, T., Shariatgorji, M., Pereira, M., Nilsson, A., Kehr, J., Andrén, P. E., Millan, M. J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00166 · Cited by 16
Interleukin‐6‐mediated signaling in adrenal medullary chromaffin cells
Jenkins, D. E., Sreenivasan, D., Carman, F. H., Samal, B. B., Eiden, L. E., & Bunn, S. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13870 · Cited by 17
Perfume, G., Morgazo, C., Nabhen, S. L., Batistone, A., Hope, S. I., Bianciotti, L. G., & Vatta, M. S. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.01.011 · Cited by 16
Perfume, G., Nabhen, S. L., Barrera, K. R., et al. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00555.2007 · Cited by 16
Mantas, I., Millan, M. J., Cara, B. D., Groenink, L., Veiga, S., Cistarelli, L., Brocco, M., Bertrand, M., Svenningsson, P., & Zhang, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168907 · Cited by 15
“Ser19 phosphorylation of TH displays faster kinetics than Ser40, which may explain the observed effects [55].”
BackgroundKasanga, E. A., Han, Y., Shifflet, M. K., Navarrete, W., McManus, R., Parry, C., Barahona, A., Nejtek, V. A., Manfredsson, F. P., Kordower, J. H., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114509 · Cited by 15
Yu, Y., Chen, W., Li, B., Li, Z., Wang, Y., Mao, Y., Fan, W., Bai, Y., Hu, H., Zhen, Q., et al. (2024) · Advanced Science · doi:10.1002/advs.202306772 · Cited by 16
Dang, D., Duong, C. X., Nam, Y., Shin, E., Lim, Y. K., Jeong, J. H., Jang, C., Nah, S.-Y., Nabeshima, T., & Kim, H. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12341 · Cited by 15
“The results of the present study supports earlier reports that PP2A is the major serine/threonine phosphatase that dephosphorylates TH, resulting in reduced TH activity.18,22 Haavik et al.22 demonstrated that PP2A was the major serine/threonine phosphatase that regulates > 90% of the dephosphorylation of TH at Ser40.”
BackgroundInfluentialPeres, T. V., Ong, L. K., Costa, A. P., et al. (2016) · Metallomics · doi:10.1039/c5mt00265f · Cited by 15
Self-citationDas, A., Verma, A., & Mukherjee, K. J. (2017) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2017.1320291 · Cited by 15
“Tyrosine hydroxylase mediated conversion of L-tyrosine to L-dopa is the rate limiting step of the catecholamine biosynthesis in human metabolism.([7,8]) However, organism such as Escherichia coli lacks the capacity to carry out posttranscriptional modification; hence, tyrosine hydroxylase is substituted by an enzyme n…”
BackgroundAlmela, P., Milanés, M. V., & Laorden, M. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.224 · Cited by 15
“Effects of morphine withdrawal of TH activity Phosphorylation of TH has been reported to increase TH activity (Dunkley et al., 2004).”
BackgroundInfluentialMutational Analysis of Catecholamine Binding in Tyrosine Hydroxylase
Briggs, G. D., Gordon, S. L., & Dickson, P. W. (2011) · Biochemistry · doi:10.1021/bi101455b · Cited by 15
Self-citationPeres, T. V., Pedro, D. Z., de Córdova, F. M., et al. (2013) · BioMed Research International · doi:10.1155/2013/769295 · Cited by 15
“Ser(40)dephosphorylation by protein phosphatase 2A (PP2A) results in decreased TH activity [33].”
BackgroundWang, S., Lasagna, M. D., Daubner, S. C., Reinhart, G. D., & Fitzpatrick, P. F. (2011) · Biochemistry · doi:10.1021/bi101844p · Cited by 15
Bobrovskaya, L., Maniam, J., Ong, L. K., Dunkley, P. R., & Morris, M. J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0985-4 · Cited by 14
“In the longer term TH is regulated by increases in TH protein which allow greater activation of TH [42].”
BackgroundInfluentialSelf-citationNabhen, S. L., Perfume, G., Battistone, M. A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9859-6 · Cited by 14
“Tyrosine hydroxylase (TH) is the enzyme that catalyzes the rate-limiting step in the synthesis of catecholamines and its activity is tightly controlled by diverse mechanisms [19–21].”
BackgroundInfluentialFauss, D., Motter, R. N., Dofiles, L., Rodrigues, M. A. V., You, M., Diep, L., Yang, Y., Seto, P., Tanaka, K., Baker, J., et al. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.03.012 · Cited by 14
Yanagihara, N., Toyohira, Y., & Shinohara, Y. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.008 · Cited by 14
Skov, L. J., Ratner, C., Hansen, N. W., Thompson, J. J., Egerod, K. L., Burm, H. B., Dalbøge, L. S., Hedegaard, M. A., Brakebusch, C., Pers, T. H., et al. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12761 · Cited by 13
Fasano, G., Godoy, R. S., Angiulli, E., Consalvo, A., Franco, C., Mancini, M., Santucci, D., Alleva, E., Ciavardelli, D., Toni, M., et al. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117151 · Cited by 13
Manganese-induced hyperactivity and dopaminergic dysfunction depend on age, sex and YAC128 genotype
Wilcox, J. M., Consoli, D. C., Paffenroth, K. C., et al. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173337 · Cited by 13
Ciliary neurotrophic factor stimulates tyrosine hydroxylase activity
Shi, X., Woodward, W. R., & Habecker, B. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07712.x · Cited by 13
“We also examined the state of TH phosphorylation on Ser31 and Ser40, sites that are thought to affect TH activity (Dunkley et al. 2004; Daubner et al. 2011) and TH turnover (Nakashima et al. 2011).”
BackgroundInfluentialDopac distribution and regulation in striatal dopaminergic varicosities and extracellular space
Wallace, L. J., & Traeger, J. (2011) · Synapse · doi:10.1002/syn.20996 · Cited by 13
“For example, activation of pre-synaptic dopamine D2 receptors is thought to lessen the extent of phosphorylation of Ser40 on the tyrosine hydroxylase protein, resulting in a decreased rate of dopamine synthesis (Dunkley et al., 2004; Lindgren et al., 2001, 2002).”
BackgroundFujikawa, T., Matsumura, S., Yamada, H., Inoue, K., & Fushiki, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.002 · Cited by 12
Bezem, M. T., Johannessen, F. G., Jung‐KC, K., Gundersen, E. T., Jorge‐Finnigan, A., Ying, M., Betbeder, D., Herfindal, L., & Martı́nez, A. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00807 · Cited by 14
Fiory, F., Mirra, P., Nigro, C., Pignalosa, F. C., Zatterale, F., Ulianich, L., Prevete, N., Formisano, P., Bèguinot, F., & Miele, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27898 · Cited by 13
Miguel, P. M., Deniz, B. F., Confortim, H. D., Bronauth, L., de Oliveira, B. C., Alves, M. B., Silveira, P. P., & Pereira, L. O. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.004 · Cited by 15
“Phosphorylated tyrosine hydroxylase (pTH) at Ser40 is positively related to the speed of dopamine synthesis (Dunkley et al., 2004) and HI animals had higher expression of pTH in both PFC hemispheres, indicating an increase in DA synthesis.”
Taveira‐da‐Silva, R., Sampaio, L. D. S., Vieyra, A. R., et al. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000497806 · Cited by 13
Matsuo, T., Izumi, Y., Wakita, S., Kume, T., Takada‐Takatori, Y., Sawada, H., & Akaike, A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.043 · Cited by 13
Tyrosine availability modulates potassium-induced striatal catecholamine efflux in vivo
Jaskiw, G. E., Newbould, E., & Bongiovanni, R. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.050 · Cited by 12
Early‐postnatal iron deficiency impacts plasticity in the dorsal and ventral hippocampus in piglets
Nelissen, E., Vry, J. D., Antonides, A., Paes, D., Schepers, M., van der Staay, F. J., Prickaerts, J., & Vanmierlo, T. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.03.006 · Cited by 12
“Iron is not only an essential micronutrient required for oxygen transport, it is also a required cofactor for key enzymes in neurotransmitter production (Beard, 2003; Dunkley et al., 2004; Wang et al., 2002).”
Lang, J. A., & Smaller, K. A. (2017) · Experimental Physiology · doi:10.1113/ep086329 · Cited by 12
“In an ‘activated state’, such as during cold or exercise stress, TH ultimately depends on increased bioavailability of both the amino acid substrate and the pterin cofactor (Kumer & Vrana, 1996; Dunkley et al. 2004).”
BackgroundScholz, J., Toska, K., Luborzewski, A., Maaß, A., Schünemann, V., Haavik, J., & Moser, A. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06365.x · Cited by 12
Proteasomal degradation of tyrosine hydroxylase and neurodegeneration
Nakashima, A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07562.x · Cited by 12
Dorofeeva, N. A., Grigorieva, Y. S., Nikitina, L. S., Lavrova, E. A., Nasluzova, E. V., Glazova, M. V., & Chernigovskaya, E. V. (2017) · Neurological Research · doi:10.1080/01616412.2017.1356156 · Cited by 12
Pires, N. M., Igreja, B., Serrão, P., Matias, E. F., Moura, E., António, T., Campos, F. L., Brion, L., Bertorello, A. M., & Soares-da-Silva, P. (2019) · Hypertension Research · doi:10.1038/s41440-019-0249-z · Cited by 13
Molecular Features of Parkinson's Disease in Patient‐Derived Midbrain Dopaminergic Neurons
Ren, Y., Jiang, H., Pu, J., Li, L., Wu, J., Yan, Y., Zhao, G., Guttuso, T. J., Zhang, B., & Feng, J. (2021) · Movement Disorders · doi:10.1002/mds.28786 · Cited by 12
Herselman, M. F., & Bobrovskaya, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914618 · Cited by 12
“According to Dunkley et al. [86], Ser31 phosphatases require the inactivation of kinases (such as ERK1/2).”
BackgroundSelf-citationKhalid, A., Ali, S., Rukhma, et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-50198-x · Cited by 11
Cassinotti, L. R., Guil, M. J., Schöller, M. I., Navarro, M., Bianciotti, L. G., & Vatta, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030660 · Cited by 12
“The specific marker of catecholaminergic neurons is TH, which catalyzes the rate limiting step in catecholamine biosynthesis [35,36].”
BackgroundInfluentialBork, K., Kannicht, C., Nöhring, S., Reutter, W. G., Weidemann, W., Hart, G. W., & Horstkorte, R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21526 · Cited by 11
“The enzymatic activity of tyrosine 3-monooxygenase is up-regulated by phosphorylation (Dunkley et al., 2004).”
BackgroundCuello, A. M. G., Mora, L., Hidalgo, J. M., Meca, N., Lasheras, C., Milanés, M. V., & Laorden, M. L. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0567-9 · Cited by 11
“Short-term regulation of catecholamines biosynthesis occurs through phosphorylation of TH, which enhances enzymatic activity (Dunkley et al. 2004).”
BackgroundEffects of Electroacupuncture on Methamphetamine‐Induced Behavioral Changes in Mice
Ho, T., Lee, C., Lu, Z., Lane, H., Tsai, M.-H., Ho, I.-K., Huang, C., & Chiang, Y. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/5642708 · Cited by 11
“A study suggested that TH phosphorylation can increase its enzyme activity [20].”
BackgroundRegulation of tyrosine hydroxylase: relevance to Parkinson's disease
Alam, G., & Richardson, J. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815950-7.00004-7 · Cited by 11
Izumi, Y., Yamamoto, N., Kume, T., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.015 · Cited by 11
Morgazo, C., Perfume, G., Legaz, G., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.168 · Cited by 11
Tiernan, C. T., Edwin, E. A., Goudreau, J. L., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft025 · Cited by 11
“Additionally, DA release is tightly coupled to synthesis, whereby end-product feedback inhibition decreases the rate of DA synthesis, and phosphorylation of tyrosine hydroxylase (TH) increases it (Dunkley et al., 2004).”
BackgroundShi, W., Wang, Y., Peng, J., Qi, S., Vitale, N., Kaneda, N., Murata, T., Luo, H., & Wu, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005767 · Cited by 11
“TH is the rate-limiting enzyme in CAT biosynthesis (32).”
BackgroundRoshdy, M., Zaky, D. A., Abbas, S. S., & Abdallah, D. M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122865 · Cited by 10
Gordon, S. L., Webb, J. K., Shehadeh, J., Dunkley, P. R., & Dickson, P. W. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9989-5 · Cited by 10
“Acute regulation of TH activity occurs via phosphorylation of three key serine (Ser) residues (Ser19, Ser31 and Ser40) [3], and also by two distinct forms of feedback inhibition by the catecholamines [4].”
Self-citationNT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity
Nakashima, A., Yamaguchi, H., Kondo, M., Furumura, T., Kodani, Y., Kaneko, Y. S., Kawata, M., Nagasaki, H., Nagatsu, T., & Ota, A. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02236-5 · Cited by 10
Zhao, Z. L., Kim, S. C., Zhang, J., et al. (2015) · Journal of Acupuncture and Meridian Studies · doi:10.1016/j.jams.2015.05.007 · Cited by 10
“TH activity is regulated by hierarchical phosphorylation at serine residues 19, 31, and 40, and evidence shows that phosphorylation at serine 40 is the most critical in enhancing TH activity [19,20].”
Douglas, S. A., & Bunn, S. J. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01821.x · Cited by 10
Effects of amphetamine on subcellular distribution of dopamine and DOPAC
Wallace, L. J. (2012) · Synapse · doi:10.1002/syn.21546 · Cited by 11
“…activity are end product inhibition by elevated levels of dopamine in the cytosol (Kilts et al., 1987; Nagatsu et al., 1964) and phosphorylation of serine 140 regulated by activation of dopamine D2 receptors on the axon terminal (Dunkley et al., 2004; Lindgren et al., 2003; Lindgren et al., 2001).”
BackgroundIron Deficiency and Neuropharmacology
Bianco, L. E., Unger, E. L., & Beard, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_8 · Cited by 9
Metadata
- Authors
- Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W.
- Affiliations
- University of Newcastle Australia (AU)
- Corresponding author
- Dunkley, Peter R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2004-11-18
- Volume
- 91
- Issue
- 5
- Pages
- 1025-1043
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2114431124
- Semantic Scholar
- f10f568903c3e4d7cdc660f6816f0563cabf919f
- Cited by
- 455
- References
- 117
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 13 · 2023: 16 · 2022: 8 · 2021: 23 · 2020: 19 · 2019: 26 · 2018: 20 · 2017: 23 · 2016: 19 · 2015: 29 · 2014: 24 · 2013: 32 · 2012: 28
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- tyrosine hydroxylase, serine phosphorylation, catecholamine synthesis, protein kinases, protein phosphatase, enzyme activation, phosphorylation stoichiometry
- MeSH terms
- Animals, Models, Biological, Phosphoprotein Phosphatases, Phosphorylation, Protein Kinases, Serine, Tyrosine 3-Monooxygenase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review